Bellicum Pharmaceuticals Company

Bellicum is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever.

Funding Status: IPO
Headquarters: United States
Founded Date: 01.07.2004
Technology: Сancer Diagnostics
Estimated Revenue: Less than $1M
Industry: Genomic and Epigenominc Instabillity